- Home
- PSNL
PSNL
Personalis Inc.
as 03-31-2025 3:42pm EST
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 460.7M | IPO Year: | 2019 |
| Target Price: | $7.80 | AVG Volume (30 days): | 940.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.14 - $7.20 | Next Earning Date: | 05-07-2025 |
| Revenue: | $84,614,000 | Revenue Growth: | 15.15% |
| Revenue Growth (this year): | -0.31% | Revenue Growth (next year): | 27.78% |
Stock Insider Trading Activity of Personalis Inc. (PSNL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Chen Richard | PSNL | CHIEF MEDICAL OFFICER AND EVP | Jan 28 '25 | Sell | $5.79 | 519 | $3,005.01 | 123,367 | |
| Tachibana Aaron | PSNL | CFO AND COO | Jan 28 '25 | Sell | $5.79 | 708 | $4,099.32 | 166,390 |
Latest Personalis Inc. News
PSNL Breaking Stock News: Dive into PSNL Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference
MT Newswires
14 days ago
Craig Hallum Initiates Coverage on Personalis With Buy Rating, $8 Price Target
Business Wire
a month ago
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
Simply Wall St.
a month ago
Personalis Full Year 2024 Earnings: Beats Expectations
GuruFocus.com
a month ago
Personalis Inc (PSNL) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
Zacks
a month ago
Personalis (PSNL) Reports Q4 Loss, Tops Revenue Estimates
Associated Press Finance
a month ago
Personalis: Q4 Earnings Snapshot
Business Wire
a month ago
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
Compare PSNL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PSNL Personalis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.